Authors defined metabolic syndrome as “the set of factors that increase the risk of cardiovascular disease and diabetes, such ...

Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...

Azerbaijan National Academy of Sciences (ANAS) has hosted a round table dedicated to the 102nd anniversary of the birth of ...

When I refer a patient to one of my ophthalmology colleagues for glaucoma or cataract surgery with a microinvasive glaucoma ...

An idealistic ophthalmologist, he came up with an ingenious way to treat blindness in far-flung places: by outfitting an ...

The highlight of this achievement is the deployment of a three-dimensional microscope visualisation system, which provides ...

The global optical imaging market is projected to experience robust growth in the coming decade, driven by continuous innovation, expanding healthcare applications, and a mounting preference for ...

April 28 marks the 102nd anniversary of the birth of Honored Scientist, Doctor of Medical Sciences, Professor, and Full ...

LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) ...

Jiarui Nie, a postdoctoral researcher at the National Institutes of Health, is exploring how gold nanoparticles injected into ...

Artificial intelligence models have immense potential for diagnosing myopia, assessing its risk factors, and predicting its ...

RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA ®, their co-developed innovative AI algorithm for Diabetic Retinopathy (DR) screening, has ...